David Reilly

2.3k total citations
23 papers, 1.6k citations indexed

About

David Reilly is a scholar working on Cancer Research, Dermatology and Molecular Biology. According to data from OpenAlex, David Reilly has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 5 papers in Dermatology and 3 papers in Molecular Biology. Recurrent topics in David Reilly's work include Protease and Inhibitor Mechanisms (10 papers), Contact Dermatitis and Allergies (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). David Reilly is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Contact Dermatitis and Allergies (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). David Reilly collaborates with scholars based in Ireland, United Kingdom and United States. David Reilly's co-authors include Francis McGlone, Michael J. Duffy, Peter A. Andreasen, N. J. O’Higgins, J. J. Fennelly, Mark R. Luettgen, Jeffrey H. Shapiro, Cardinal Warde, Peter S. Walker and F C Ewald and has published in prestigious journals such as Cancer, Scientific Reports and Neuroscience & Biobehavioral Reviews.

In The Last Decade

David Reilly

22 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Reilly Ireland 16 427 276 269 243 209 23 1.6k
Farhad Hafezi Switzerland 48 112 0.3× 95 0.3× 169 0.6× 2.0k 8.1× 41 0.2× 233 8.5k
Doris Dahl United States 32 148 0.3× 111 0.4× 315 1.2× 2.3k 9.5× 338 1.6× 70 4.4k
Konstantina M. Stanković United States 37 127 0.3× 416 1.5× 360 1.3× 772 3.2× 77 0.4× 162 4.3k
Toshio Yamashita Japan 26 39 0.1× 134 0.5× 254 0.9× 335 1.4× 138 0.7× 245 2.4k
Assen Koitschev Germany 22 52 0.1× 262 0.9× 64 0.2× 407 1.7× 68 0.3× 76 1.8k
Thai Nguyen United States 31 145 0.3× 34 0.1× 115 0.4× 2.3k 9.6× 150 0.7× 59 4.9k
Shizuo Komune Japan 30 1.3k 3.0× 127 0.5× 620 2.3× 1.8k 7.6× 70 0.3× 241 4.5k
Young C. Jang United States 24 135 0.3× 102 0.4× 188 0.7× 1.9k 7.8× 25 0.1× 53 3.8k
Pan Li China 20 37 0.1× 104 0.4× 145 0.5× 316 1.3× 209 1.0× 47 1.8k
Marimélia Porcionatto Brazil 29 139 0.3× 25 0.1× 113 0.4× 933 3.8× 115 0.6× 92 2.4k

Countries citing papers authored by David Reilly

Since Specialization
Citations

This map shows the geographic impact of David Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Reilly more than expected).

Fields of papers citing papers by David Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Reilly. The network helps show where David Reilly may publish in the future.

Co-authorship network of co-authors of David Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of David Reilly. A scholar is included among the top collaborators of David Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Reilly. David Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Reilly, David, et al.. (2021). Skin collagen through the lifestages: importance for skin health and beauty. Plastic and Aesthetic Research. 8. 2–2. 163 indexed citations
3.
Reilly, David, Magdalena S. Mroz, Eugene Dempsey, et al.. (2017). Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis. Scientific Reports. 7(1). 7642–7642. 63 indexed citations
4.
McGlone, Francis & David Reilly. (2009). The cutaneous sensory system. Neuroscience & Biobehavioral Reviews. 34(2). 148–159. 310 indexed citations
5.
Fairweather, I., Francis McGlone, David Reilly, & Roman Rukwied. (2004). Controlled dermal cell damage as human in vivo model for localised pain and inflammation. Inflammation Research. 53(3). 118–123. 8 indexed citations
6.
Reilly, David, et al.. (2004). Unique properties of solar blind ultraviolet communication systems for unattended ground-sensor networks. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 5611. 244–244. 67 indexed citations
7.
Reilly, David. (2000). Inflammatory Mediators in Normal, Sensitive and Diseased Skin Types: Investigative Report. Acta Dermato Venereologica. 80(3). 171–174. 64 indexed citations
8.
Reilly, David. (1999). Eicosanoid and Cytokine Levels in Acute Skin Irritation in Response to Tape Stripping and Capsaicin. Acta Dermato Venereologica. 79(3). 187–190. 23 indexed citations
9.
Reilly, David, et al.. (1997). The epidermal nerve fibre network: characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variations. British Journal of Dermatology. 137(2). 163–170. 73 indexed citations
10.
Duffy, Michael J., David Reilly, E. McDermott, et al.. (1994). Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer. Cancer. 74(8). 2276–2280. 58 indexed citations
11.
Reilly, David, et al.. (1992). Type‐1 plasminogen activator inhibitor in human breast carcinomas. International Journal of Cancer. 50(2). 208–214. 88 indexed citations
12.
Duffy, M. J., David Reilly, J.P. Brouillet, et al.. (1992). Cathepsin D Concentration in Breast Cancer Cytosols: Correlation with Disease-Free Interval and Overall Survival. Clinical Chemistry. 38(10). 2114–2116. 30 indexed citations
13.
Reilly, David, Peter A. Andreasen, Mogens Duch, et al.. (1992). Plasminogen activator inhibitor type 1 and 2 in human breast cancer. Biochemical Society Transactions. 20(1). 88S–88S. 5 indexed citations
14.
Reilly, David, et al.. (1991). Pancreatic Injuries. AORN Journal. 53(4). 917–918. 4 indexed citations
15.
Reilly, David, P.A. Andreasen, & Michael J. Duffy. (1991). Urokinase-plasminogen activator in breast cancer. Blood Coagulation & Fibrinolysis. 2(1). 47–50. 30 indexed citations
16.
Duffy, M. J., J.P. Brouillet, David Reilly, et al.. (1991). Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings. Clinical Chemistry. 37(1). 101–104. 49 indexed citations
17.
Duffy, Michael J., et al.. (1990). Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.. PubMed. 50(21). 6827–9. 260 indexed citations
18.
Reilly, David, et al.. (1989). Urokinase-type plasminogen activator and its inhibitor PAI-1 in human breast cancer. Biochemical Society Transactions. 17(3). 609–609. 1 indexed citations
19.
Reilly, David, et al.. (1982). Effects of Tibial Components on Load Transfer in the Upper Tibia. Clinical Orthopaedics and Related Research. 165(165). 273–282. 97 indexed citations
20.
Reilly, David & Cardinal Warde. (1979). Temporal characteristics of single-scatter radiation. Journal of the Optical Society of America. 69(3). 464–464. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026